Bone Marrow Transplantation
49
5
5
37
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.0%
1 terminated out of 49 trials
97.4%
+10.9% vs benchmark
8%
4 trials in Phase 3/4
5%
2 of 37 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 37 completed trials
Clinical Trials (49)
Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors
Effect of BMT Educational Guidelines on Nurses' Skills
National Longitudinal Cohort of Hematological Diseases
Impact of Physical and Occupational Therapy in New BMT Patients
The Oronasal Microbiota in Pediatric Oncology Patients
High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
Biomarkers in Transplant Recipients to Improve Outcomes
Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC)
Impact of Yoga and Gentle Massage Practices on Symptom Management in Patients Undergoing HSCT
Collection of Samples and Data for the National Marrow Donor Program Repository
Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Physical Activity Monitoring Among BMT Patients
Effects of Orange Oil Aromatherapy on the Pain and Anxiety
Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease
Evolution of the Energy Expenditure During Hematopoietic Stem Cell Transplantation
King's Invasive Aspergillosis Study II
Valacyclovir in Immunocompromised Children
Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers
Toward Immune Biomarkers for Tolerance and GvHD in Humans
Forced Oscillations for Diagnosis Help in Bronchiolitis Obliterans Syndrome in Post Bone Marrow Transplantation